Tanke Biosciences Corp Announces the Appointment of John P. Hopkins Executive Chairman of the Board of Directors
Tanke Biosciences Corp (OTC: TNBI) has appointed John P. Hopkins as Executive Chairman of the Board of Directors, effective March 31st, 2025. Hopkins brings 40 years of experience in senior accounting, finance, operations, business turnarounds, and M&A.
Hopkins' track record includes serving as President and CEO of Professional Security Broadband Inc., where he quadrupled revenue before private equity acquisition. As CFO at Measurement Specialties (NASDAQ), he led financial restructuring during an SEC investigation, leading to a $1.7b company sale. At Henry Bros. Electronics (NASDAQ), he increased market cap by 130% before acquisition.
Currently an adjunct associate professor at NYU's Stern School of Business, Hopkins holds an MBA from Villanova University and is a certified public accountant. The appointment aligns with TNBI's strategy as an emerging diversified holding company focused on identifying and scaling growth-stage businesses.
Tanke Biosciences Corp (OTC: TNBI) ha nominato John P. Hopkins come Presidente Esecutivo del Consiglio di Amministrazione, con effetto dal 31 marzo 2025. Hopkins porta con sé 40 anni di esperienza in contabilità senior, finanza, operazioni, ristrutturazioni aziendali e fusioni e acquisizioni.
Il percorso professionale di Hopkins include il ruolo di Presidente e CEO di Professional Security Broadband Inc., dove ha quadruplicato i ricavi prima dell'acquisizione da parte di un fondo di private equity. Come CFO di Measurement Specialties (NASDAQ), ha guidato una ristrutturazione finanziaria durante un'indagine della SEC, portando alla vendita dell'azienda per 1,7 miliardi di dollari. Presso Henry Bros. Electronics (NASDAQ), ha aumentato la capitalizzazione di mercato del 130% prima dell'acquisizione.
Attualmente è professore associato a contratto presso la Stern School of Business della NYU, Hopkins possiede un MBA della Villanova University ed è un commercialista certificato. La nomina è in linea con la strategia di TNBI come società di holding diversificata emergente, focalizzata sull'identificazione e sulla crescita di aziende in fase di sviluppo.
Tanke Biosciences Corp (OTC: TNBI) ha nombrado a John P. Hopkins como Presidente Ejecutivo de la Junta Directiva, con efecto a partir del 31 de marzo de 2025. Hopkins aporta 40 años de experiencia en contabilidad senior, finanzas, operaciones, reestructuraciones empresariales y fusiones y adquisiciones.
El historial de Hopkins incluye haber sido Presidente y CEO de Professional Security Broadband Inc., donde cuadruplicó los ingresos antes de la adquisición por parte de un fondo de capital privado. Como CFO en Measurement Specialties (NASDAQ), lideró la reestructuración financiera durante una investigación de la SEC, lo que llevó a la venta de la empresa por 1.7 mil millones de dólares. En Henry Bros. Electronics (NASDAQ), aumentó la capitalización de mercado en un 130% antes de la adquisición.
Actualmente, es profesor asociado adjunto en la Stern School of Business de NYU, Hopkins tiene un MBA de la Universidad de Villanova y es contador público certificado. La designación está alineada con la estrategia de TNBI como una empresa holding diversificada emergente centrada en identificar y escalar negocios en etapa de crecimiento.
Tanke Biosciences Corp (OTC: TNBI)는 John P. Hopkins을 이사회 의장으로 임명했습니다. 임기는 2025년 3월 31일부터 시작됩니다. Hopkins는 고위 회계, 재무, 운영, 기업 재구성 및 M&A 분야에서 40년의 경험을 가지고 있습니다.
Hopkins의 경력은 Professional Security Broadband Inc.의 사장 겸 CEO로 재직하면서 사모펀드 인수 전에 매출을 4배로 늘린 것을 포함합니다. Measurement Specialties(NASDAQ)에서 CFO로 재직하면서 SEC 조사 중 재무 구조 조정을 이끌어 17억 달러에 회사를 매각했습니다. Henry Bros. Electronics(NASDAQ)에서는 인수 전에 시장 가치를 130% 증가시켰습니다.
현재 NYU의 Stern School of Business에서 부교수로 재직 중인 Hopkins는 Villanova University에서 MBA를 취득했으며, 공인 회계사입니다. 이번 임명은 TNBI가 성장 단계의 기업을 발굴하고 확장하는 데 집중하는 신흥 다각화 지주회사로서의 전략에 부합합니다.
Tanke Biosciences Corp (OTC: TNBI) a nommé John P. Hopkins au poste de Président Exécutif du Conseil d'Administration, à compter du 31 mars 2025. Hopkins apporte 40 ans d'expérience dans la comptabilité senior, la finance, les opérations, les retournements d'entreprises et les fusions-acquisitions.
Le parcours de Hopkins comprend un poste de Président et CEO de Professional Security Broadband Inc., où il a quadruplé le chiffre d'affaires avant l'acquisition par un fonds de capital-investissement. En tant que CFO chez Measurement Specialties (NASDAQ), il a dirigé une restructuration financière pendant une enquête de la SEC, menant à la vente de l'entreprise pour 1,7 milliard de dollars. Chez Henry Bros. Electronics (NASDAQ), il a augmenté la capitalisation boursière de 130 % avant l'acquisition.
Actuellement professeur associé à la Stern School of Business de la NYU, Hopkins détient un MBA de l'Université Villanova et est expert-comptable certifié. La nomination s'inscrit dans la stratégie de TNBI en tant que société de holding diversifiée émergente, axée sur l'identification et la mise à l'échelle d'entreprises en phase de croissance.
Tanke Biosciences Corp (OTC: TNBI) hat John P. Hopkins zum Executive Chairman des Board of Directors ernannt, mit Wirkung zum 31. März 2025. Hopkins bringt 40 Jahre Erfahrung in der Seniorbuchhaltung, Finanzen, Betrieb, Unternehmensumstrukturierungen und M&A mit.
Hopkins' Erfolgsbilanz umfasst die Tätigkeit als Präsident und CEO von Professional Security Broadband Inc., wo er den Umsatz vor der Übernahme durch Private Equity vervierfachte. Als CFO bei Measurement Specialties (NASDAQ) leitete er die finanzielle Umstrukturierung während einer SEC-Untersuchung, die zum Verkauf des Unternehmens für 1,7 Milliarden Dollar führte. Bei Henry Bros. Electronics (NASDAQ) steigerte er die Marktkapitalisierung um 130% vor der Übernahme.
Derzeit ist er außerordentlicher Professor an der Stern School of Business der NYU, Hopkins hat einen MBA von der Villanova University und ist ein zertifizierter Wirtschaftsprüfer. Die Ernennung steht im Einklang mit der Strategie von TNBI als aufstrebendes diversifiziertes Holdingunternehmen, das sich auf die Identifizierung und Skalierung von Wachstumsunternehmen konzentriert.
- Appointment of experienced executive with proven track record in business turnarounds
- New Chairman's history of successful M&A deals and company sales
- Strong financial expertise with public company CFO experience
- Demonstrated ability to drive revenue growth and market cap increases in previous roles
- None.
Las Vegas, Nevada, April 07, 2025 (GLOBE NEWSWIRE) -- Tanke Biosciences Corp (the “Company”) (OTC: TNBI) announced today that John P. Hopkins has been appointed Executive Chairman of the Company’s Board of Directors, effective March 31st, 2025.
Mr. Hopkins has 40 years of experience in senior accounting, finance and operations, business turnarounds and M&A. Most recently, Mr. Hopkins served as the President and Chief Executive Officer of Professional Security Broadband Inc., where he was responsible for organically quadrupling revenue prior to being acquired by a private equity firm. John’s first public CFO appointment was at Measurement Specialties, a NASDAQ company, that is a leading global designer and manufacturer of sensors and sensor-based systems. Joining during a critical SEC investigation, he successfully led the financial restructuring efforts, returning the company to profitability and laying the groundwork for an eventual sale of the company for
CEO, Vincent Renz, stated “John’s extensive experiences in leading businesses will greatly compliment the seasoned management, advisory and operational team that we are assembling.John has actively been involved in academia and in 2020 he joined NYU’s Stern School of Business as an adjunct associate professor, where he teaches a number of courses to both undergraduate and MBA students.
Mr. Hopkins stated, “There is no replacement for business acumen and experience in successful companies and I look forward as Executive Chairman of The Board to working with Vinnie in assembling a deeply talented and experienced management and advisory team to identify, build and invest in businesses positioned to scale.”
Mr. Hopkins is a certified public accountant and holds an MBA from Villanova University and a bachelor’s degree in accounting from West Chester University. John volunteers teaching eighth graders as part of the Junior Achievement in the West Kensington section of Philadelphia. John also remains engaged competitively in rowing crew on boathouse row in Philadelphia.
Tanke Biosciences Corp
Tanke Biosciences Corp (OTC: TNBI) is an emerging diversified holding company focused on identifying emerging, growth stage businesses, which have achieved some level of revenue traction, proof of concept, and/or customer/market adoption, in order to provide them with the capital and management resources to scale profitable growth and drive shareholder value through leadership in their respective market areas. Based in Delray Beach, Florida and Newark, New Jersey, the management, advisors and the Board of Directors of the Company bring decades of tangible leadership expertise driving strong growth in organizations of all sizes through strategic capital injection, revenue growth & expansion and operational excellence.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "predict," "project," "should," and "will" and variations of such words and similar expressions are intended to identify such forward-looking statements. All statements in this press release pertaining to our expectations constitute forward-looking statements. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties, including, but not limited to, the accuracy of our estimates regarding expenses, capital requirements and need for additional financing, our ability to operate our business and generate profits, decline in global financial markets and economic downturns, unforeseen business interruptions, and general risk factors affecting our industry.
Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. We expressly disclaim any current intention to update publicly any forward-looking statement after the distribution of this release, whether as a result of new information, future events, changes in assumptions or otherwise.
For further information please reach out to:
hello(at)brandcraftholdings.com
Source: Tanke Biosciences Corp.
hello (at) brandcraftholdings.com
FAQ
What is John Hopkins' track record in turning around companies before joining TNBI?
When does John Hopkins start his role as Executive Chairman at TNBI?
What is TNBI's current business strategy as a holding company?
What are John Hopkins' academic credentials and current teaching position?
